Pathomorphological features of inflammatory infiltrate in colorectal cancer
DOI:
https://doi.org/10.14739/2310-1237.2025.1.317202Keywords:
colorectal cancer, tumor microenvironment, pathomorphologyAbstract
Aim: to investigate the pathomorphological features and severity of inflammatory infiltration in colorectal cancers.
Materials and methods. A morphological study of surgical and biopsy material of patients with colon adenocarcinoma of various degrees of differentiation (n = 38) and mucinous adenocarcinoma (n = 7) was performed. Histological specimens were examined morphologically with morphometric analysis. The results were processed by descriptive statistics by calculating the median (Me) for quantitative variables. The statistical significance of the difference between the parameters was evaluated based on the Mann–Whitney U test.
Results. It was found that intestinal carcinoma developed on the background of chronic inflammation. Dysplasia was often detected in the glands, gradually increasing with an approach to the tumor tissue. In the tumor’s microenvironment, there were cells of the immune system: lymphocytes, macrophages, plasma cells, and cells of the myeloid lineage. In the absence of destructive changes in the tumor tissue, lymphocytes and macrophages predominated in the inflammatory microenvironment. In the conditionally standardized field of view of 100 × 100 μm (CSFV), the number of cells was 77.50 (72.25; 84.25), in the edges of the resection – 12.50 (9.00; 16.00). The development of necrotic changes led to a change in cellular representation with a significant increase in myeloid cells. In 3 cases, a significant number of eosinophils was found in the inflammatory, mainly peritumoral infiltrate, at the level of 14.5 (11.00; 18.00) in the CSFV. Invasive tumor growth with penetration into the muscle layer was accompanied by a decrease in inflammatory infiltration. The number of cells in the CSFV was 49.70 (43.50; 54.80). When the tumor invaded the entire thickness of the intestinal wall at the border with adipose tissue, the number of cells in the CSFV was 28.50 (21.45; 33.75). Mucin-producing carcinoma was characterized by a lower intensity of inflammatory infiltrate. The number of cells in the CSFV in the mucosal lamina propria in mucin-producing carcinoma was 42.40 (35.65; 48.55). At the border with the muscular layer and in case of invasion into the intestinal wall thickness, the number of inflammatory infiltrate cells decreased and amounted to 26.50 (18.90; 32.40) and 18.75 (14.00; 22.30), respectively. In areas of severe sclerotic changes, inflammatory infiltration was not detected. Tumor invasion into adipose tissue was accompanied by a mild diffuse inflammatory infiltrate in the surrounding tissues, at the level of 12.50 (7.40; 16.45) cells in the CSFV.
Conclusions. The inflammatory infiltration in the intestinal mucosa in colorectal carcinoma is represented by lymphocytes, macrophages, plasma cells and cells of myeloid lineage and is maximally expressed in the intestinal mucosa. Invasion of the adenocarcinoma into the muscle layer and invasion of the entire intestinal wall is accompanied by a decrease in peritumor inflammatory infiltration. Mucin-producing carcinoma is characterized by a lower intensity of inflammatory infiltrate compared to tubular adenocarcinoma.
References
Siegel RL, Wagle NS, Cercek A, Smith RA, Jemal A. Colorectal cancer statistics, 2023. CA Cancer J Clin. 2023;73(3):233-54. doi: https://doi.org/10.3322/caac.21772
Shin AE, Giancotti FG, Rustgi AK. Metastatic colorectal cancer: mechanisms and emerging therapeutics. Trends Pharmacol Sci. 2023;44(4):222-36. doi: https://doi.org/10.1016/j.tips.2023.01.003
Nardone OM, Zammarchi I, Santacroce G, Ghosh S, Iacucci M. Inflammation-Driven Colorectal Cancer Associated with Colitis: From Pathogenesis to Changing Therapy. Cancers (Basel). 2023;15(8):2389. doi: https://doi.org/10.3390/cancers15082389
Liu W, Kuang T, Liu L, Deng W. The role of innate immune cells in the colorectal cancer tumor microenvironment and advances in anti-tumor therapy research. Front Immunol. 2024;15:1407449. doi: https://doi.org/10.3389/fimmu.2024.1407449
Germann M, Zangger N, Sauvain MO, Sempoux C, Bowler AD, Wirapati P, et al. Neutrophils suppress tumor-infiltrating T cells in colon cancer via matrix metalloproteinase-mediated activation of TGFβ. EMBO Mol Med. 2020;12(1):e10681. doi: https://doi.org/10.15252/emmm.201910681
Yahaya M, Lila M, Ismail S, Zainol M, Afizan N. Tumour-Associated Macrophages (TAMs) in Colon Cancer and How to Reeducate Them. J Immunol Res. 2019;2019:2368249. doi: https://doi.org/10.1155/2019/2368249
Lecoultre M, Dutoit V, Walker PR. Phagocytic function of tumor-associated macrophages as a key determinant of tumor progression control: a review. J Immunother Cancer. 2020;8(2):e001408. doi: https://doi.org/10.1136/jitc-2020-001408
Luo C, Cen S, Ding G, Wu W. Mucinous colorectal adenocarcinoma: clinical pathology and treatment options. Cancer Commun (Lond). 2019;39(1):13. doi: https://doi.org/10.1186/s40880-019-0361-0
Li J, Yang L, Bai F, Cai Y, Zhang J, Wu Z, et al. Clinicopathological, molecular features and prognosis of colorectal cancer with mucinous component. Future Oncol. 2021;17(11):1351-62. doi: https://doi.org/10.2217/fon-2020-1055
Hinshaw DC, Shevde LA. The Tumor Microenvironment Innately Modulates Cancer Progression. Cancer Res. 2019;79(18):4557-66. doi: https://doi.org/10.1158/0008-5472.CAN-18-3962
Picard E, Verschoor CP, Ma GW, Pawelec G. Relationships Between Immune Landscapes, Genetic Subtypes and Responses to Immunotherapy in Colorectal Cancer. Front Immunol. 2020;11:369. doi: https://doi.org/10.3389/fimmu.2020.00369
Zhao Y, Ge X, He J, Cheng Y, Wang Z, Wang J, et al. The prognostic value of tumor-infiltrating lymphocytes in colorectal cancer differs by anatomical subsite: a systematic review and meta-analysis. World J Surg Oncol. 2019;17(1):85. doi: https://doi.org/10.1186/s12957-019-1621-9
Coppola A, Arriga R, Lauro D, Del Principe MI, Buccisano F, Maurillo L, et al. NK Cell Inflammation in the Clinical Outcome of Colorectal Carcinoma. Front Med (Lausanne). 2015;2:33. doi: https://doi.org/10.3389/fmed.2015.00033
Maiorino L, Daßler-Plenker J, Sun L, Egeblad M. Innate Immunity and Cancer Pathophysiology. Annu Rev Pathol. 2022;17:425-57. doi: https://doi.org/10.1146/annurev-pathmechdis-032221-115501
Xiong S, Dong L, Cheng L. Neutrophils in cancer carcinogenesis and metastasis. J Hematol Oncol. 2021;14(1):173. doi: https://doi.org/10.1186/s13045-021-01187-y
Zhang M, Li X, Zhang Q, Yang J, Liu G. Roles of macrophages on ulcerative colitis and colitis-associated colorectal cancer. Front Immunol. 2023;14:1103617. doi: https://doi.org/10.3389/fimmu.2023.1103617
Chen T, Wang Y, Nan Z, Wu J, Li A, Zhang T, et al. Interaction Between Macrophage Extracellular Traps and Colon Cancer Cells Promotes Colon Cancer Invasion and Correlates With Unfavorable Prognosis. Front Immunol. 2021;12:779325. doi: https://doi.org/10.3389/fimmu.2021.779325
Li S, Hao L, Hu X. Biological Roles and Clinical Therapeutic Applications of Tumor-Associated Macrophages in Colorectal Liver Metastasis. J Inflamm Res. 2024;17:8429-43. doi: https://doi.org/10.2147/JIR.S493656
Burgos-Molina AM, Téllez Santana T, Redondo M, Bravo Romero MJ. The Crucial Role of Inflammation and the Immune System in Colorectal Cancer Carcinogenesis: A Comprehensive Perspective. Int J Mol Sci. 2024;25(11):6188. doi: https://doi.org/10.3390/ijms25116188
Zheng W, Wu J, Peng Y, Sun J, Cheng P, Huang Q. Tumor-Associated Neutrophils in Colorectal Cancer Development, Progression and Immunotherapy. Cancers (Basel). 2022;14(19):4755. doi: https://doi.org/10.3390/cancers14194755
Lopez-Perez D, Prados-Lopez B, Galvez J, Leon J, Carazo A. Eosinophils in Colorectal Cancer: Emerging Insights into Anti-Tumoral Mechanisms and Clinical Implications. Int J Mol Sci. 2024;25(11):6098. doi: https://doi.org/10.3390/ijms25116098
Varricchi G, Galdiero MR, Loffredo S, Lucarini V, Marone G, Mattei F, et al. Eosinophils: The unsung heroes in cancer? Oncoimmunology. 2017;7(2):e1393134. doi: https://doi.org/10.1080/2162402X.2017.1393134
Yamamoto Y, Kasashima H, Fukui Y, Tsujio G, Yashiro M, Maeda K. The heterogeneity of cancer-associated fibroblast subpopulations: Their origins, biomarkers, and roles in the tumor microenvironment. Cancer Sci. 2023;114(1):16-24. doi: https://doi.org/10.1111/cas.15609
Saw PE, Chen J, Song E. Targeting CAFs to overcome anticancer therapeutic resistance. Trends Cancer. 2022;8(7):527-55. doi: https://doi.org/10.1016/j.trecan.2022.03.001
Downloads
Additional Files
Published
How to Cite
Issue
Section
License
Copyright (c) 2025 S. I. Tertyshnyi, O. H. Chucha

This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.